Mutations in these two genes increase the risk for BC and BRCA2 is also related to increase risk for prostate cancer even as CHEK2 increases risk for colorectal cancer, probably explaining the family history of cancer at multiple distinct sites. This evidence concerns the gene CHEK2 and cancer.